Is DIM (diindolylmethane) FDA-approved?

DIM (diindolylmethane) is regulated as a dietary supplement in the US, not as a drug. The FDA does not verify efficacy claims on supplement labels, and product potency varies by brand. Discuss any supplement with a qualified clinician before starting.

Does DIM (diindolylmethane) help with estrogen metabolism?

Speak to a clinician before starting DIM (diindolylmethane) if you are pregnant, breastfeeding, taking prescription medication (especially CYP1A2, CYP2C9, CYP3A4 substrates), or living with a chronic condition. Overall, our editorial synthesis rates the evidence as "insufficient evidence" — it is not a substitute for medical care.

DIM (diindolylmethane) is regulated as a dietary supplement in the US, not as a drug. The FDA does not verify efficacy claims on supplement labels, and product potency varies by brand. Discuss any supplement with a qualified clinician before starting.

Editorial evidence review

DIM (diindolylmethane) for estrogen metabolism: what the evidence shows

Also known as: 3,3'-diindolylmethane, indole-3-carbinol metabolite, cruciferous vegetable extract

Evidence grade

Insufficient evidence

DIM is a metabolite of compounds in cruciferous vegetables. Small pilot studies suggest it may shift urinary estrogen-metabolite ratios, but well-controlled trials showing meaningful clinical benefit for PMS, acne, or menopausal symptoms are lacking. Popular "estrogen dominance" framing outpaces the evidence.

What is DIM (diindolylmethane)?

DIM (diindolylmethane) (3,3'-diindolylmethane) is a dietary supplement commonly marketed for estrogen metabolism, estrogen dominance concerns, hormonal acne. In the US it is regulated as a food, not a drug, so the FDA does not verify label claims or potency. This page summarizes what peer-reviewed research suggests about DIM (diindolylmethane) and how clinicians typically weigh it against evidence-based prescription options.

Evidence for menopause and hormonal-health uses

Researchers have studied DIM (diindolylmethane) for several symptom clusters relevant to women in perimenopause and midlife. The strongest evidence, where it exists, is summarized below — framed as what studies suggest rather than as clinical guarantees.

estrogen metabolism: studies suggest insufficient controlled data to draw a reliable conclusion.
estrogen dominance concerns: studies suggest insufficient controlled data to draw a reliable conclusion.
hormonal acne: studies suggest insufficient controlled data to draw a reliable conclusion.
PMS: studies suggest insufficient controlled data to draw a reliable conclusion.
breast tenderness: studies suggest insufficient controlled data to draw a reliable conclusion.

Typical dosing

Common label doses range 100–200 mg/day of a stabilized preparation. There is no consensus therapeutic dose because clinical endpoints are not well established.

Dosing above is what studies commonly use — it is not a personal medical recommendation.

Side effects and interactions

Common side effects

Darkening of urine (harmless pigment change)
Headache
Gastrointestinal upset
Menstrual cycle changes

Known interactions

CYP1A2, CYP2C9, CYP3A4 substrates — DIM induces these enzymes and may reduce drug levels
Hormonal contraception — theoretical reduced efficacy
Tamoxifen and aromatase inhibitors — discuss with oncologist before use
Anticoagulants — theoretical interaction

Who should avoid DIM (diindolylmethane)

Speak to a qualified clinician before starting DIM (diindolylmethane) if you are pregnant, planning pregnancy, breastfeeding, taking prescription medication, or living with a hormone-sensitive condition, kidney or liver disease, a bleeding disorder, or a thyroid condition. Supplement quality varies by manufacturer, so avoid products that do not disclose third-party testing.

Evidence-based alternatives and clinician-guided options

If you are considering DIM (diindolylmethane) for perimenopause or midlife hormonal symptoms, a clinician can help weigh it against options with a stronger evidence base — including hormone therapy, non-hormonal prescriptions, and lifestyle interventions. Our editorial reviews cover telehealth providers that can prescribe and monitor these options:

Read our alloy review — Alloy clinicians evaluate labs and evidence-based estrogen therapy rather than empiric supplements.
Read our winona review — Winona offers medically-supervised menopause therapy — a clinician-guided alternative to self-directed DIM use.

Weighing costs matters too — our HRT cost estimator compares typical monthly out-of-pocket costs across HRT, non-hormonal Rx, and supplement-only strategies.

Frequently asked questions

Does DIM (diindolylmethane) help with estrogen metabolism?: DIM is a metabolite of compounds in cruciferous vegetables. Small pilot studies suggest it may shift urinary estrogen-metabolite ratios, but well-controlled trials showing meaningful clinical benefit for PMS, acne, or menopausal symptoms are lacking. Popular "estrogen dominance" framing outpaces the evidence.
What is a typical dose of DIM (diindolylmethane)?: Common label doses range 100–200 mg/day of a stabilized preparation. There is no consensus therapeutic dose because clinical endpoints are not well established.
Who should avoid DIM (diindolylmethane)?: Speak to a clinician before starting DIM (diindolylmethane) if you are pregnant, breastfeeding, taking prescription medication (especially CYP1A2, CYP2C9, CYP3A4 substrates), or living with a chronic condition. Overall, our editorial synthesis rates the evidence as "insufficient evidence" — it is not a substitute for medical care.
Is DIM (diindolylmethane) FDA-approved?: DIM (diindolylmethane) is regulated as a dietary supplement in the US, not as a drug. The FDA does not verify efficacy claims on supplement labels, and product potency varies by brand. Discuss any supplement with a qualified clinician before starting.